Summary

  • Mount Sinai has not said whether the Epstein-related review has concluded, what the review found, or whether the Dubins’ departure was connected to the review.
  • Department of Justice files document hundreds of thousands of dollars in Epstein donations to Mount Sinai after the 2008 conviction, with the files indicating the donations carried “VIP” status at the hospital.
  • The New York Times reported that Mount Sinai surgeon Dr Jess Ting sewed 35 stitches into a young Russian woman’s forehead inside Epstein’s Upper East Side townhouse in October 2012.
  • The New York State Department of Health said the allegations in recent media reports are deeply troubling and clearly warrant review.
  • The Dubins’ departures change Mount Sinai’s board composition without establishing, on the available record, that the couple knew of Epstein’s alleged conduct or left because of the scrutiny.

Glenn Dubin and Eva Andersson-Dubin have left Mount Sinai’s boards without a public account from the hospital linking their departure to the scrutiny around the couple’s ties to Jeffrey Epstein. Mount Sinai’s only causal account is its statement that the Dubins’ terms on the board of trustees ended this past spring and that they did not seek re-election. The hospital has not said whether the Epstein-related review it reportedly formed earlier this year has concluded, what the review found, or whether the review was connected to the departure. On the available evidence, the departures change formal governance without establishing that the Dubins knew of Epstein’s alleged conduct or left because of the scrutiny. The record assembled from Department of Justice files, court filings, and prior reporting establishes association and financial interrelation more firmly than it establishes knowledge, and the unresolved review leaves institutional controls unverified.

The departure and the review’s status

Earlier this year Mount Sinai reportedly formed a committee to review its longstanding ties to Epstein. The hospital’s statement on the Dubins — “The Dubins’ terms on the board of trustees ended this past spring, and they did not seek re-election” — did not say whether the Epstein-related review had concluded, what the review found, or whether the review was connected to the departure. That tripartite non-answer is the one the record returns to at every point: the hospital has not disclosed whether the review has concluded, what the review found, or whether the departures were connected to it.

A spokesperson for the Dubins said: “Had they been aware of Epstein’s vile and unspeakable conduct, they would have cut off all ties long ago and certainly never allowed him to be in the presence of their children.” In July 2019 the spokesperson said the couple were “horrified” by the allegations of Epstein’s sex trafficking and stated: “The Dubins were loyal friends and mistakenly believed Mr Epstein, a person they had known for decades, had rehabilitated himself after his 2008 plea and deserved a second chance.” Those statements assert a state of mind; the public record documents continued association after the 2008 conviction and cannot independently confirm or refute what the couple knew when.

The documentary timeline places the departure between two institutional records. The couple were still listed as members of the hospital’s boards of trustees in a May 2025 journal marking the hospital’s 40th anniversary Crystal Party. In the journal for the 41st annual Crystal Party, held this past May, neither Glenn Dubin nor Eva Andersson-Dubin appeared on the boards of trustees list, which included members as of March 31, 2026.

Who benefits

The public record traces several channels through which the relationships produced benefits, without establishing who knew what.

Board and governance standing. Dubin served on the board of trustees from 2007, including as vice-chair, and Andersson-Dubin stepped down earlier this year from the Icahn School of Medicine board. Leon Black served on the board of trustees from 2001 to 2012 and on the Icahn board through 2024. Brad Karp has served on the board since 2019 and remains on it after resigning the chairmanship of Paul, Weiss earlier this year, following emails released in the Epstein files that revealed extensive personal and business communications with Epstein; Paul, Weiss has said Karp “regrets” his interactions with Epstein.

Named philanthropy converted into institutional position. According to Department of Justice files released in January, Epstein donated hundreds of thousands of dollars to Mount Sinai and its medical school in the years following his 2008 conviction on state charges, and the files indicate the donations gave Epstein “VIP” status at the hospital. In 2000, Black and his wife endowed the Debra and Leon Black Professor of Pediatrics chair at Icahn, and in 2005 they established Mount Sinai’s Black Family Stem Cell Institute. In 2010 the Dubins established Mount Sinai’s Dubin Breast Center, now a 15,000 sq ft facility inside the main campus with a Fifth Avenue entrance marked by a hot-pink awning.

Clinical access outside institutional settings. The New York Times reported that Dr Jess Ting, an assistant professor of surgery at Mount Sinai, sewed 35 stitches into the forehead of a young Russian woman inside Epstein’s Upper East Side townhouse in October 2012, after she injured herself riding an ATV on Epstein’s Caribbean island. The Times published an undated color photograph that appeared to show the surgeon performing the procedure in Epstein’s dining room.

Research funding and acknowledgment. Four months after the procedure, in February 2013, Epstein directed his accountant, Richard Kahn, to make out a check to Mount Sinai for $50,000; an email written by Ting described the money as “earmarked” for research. Four years later, Ting co-authored an article about an experiment related to “aggressive sporadic breast cancer” in Clinical Cancer Research, a peer-reviewed medical journal; the article’s acknowledgements noted that the research was supported by donations from, among others, “Jeffrey Epstein to JT.” Tax records for the Icahn School of Medicine show Ting received $4.6m in compensation in 2019. The reporting does not establish that the check compensated the procedure.

Informal personnel channels. Epstein files show that Andersson-Dubin and Epstein communicated frequently about many topics, and that she reportedly served as Epstein’s “conduit” to Mount Sinai. According to Department of Justice emails, in April 2012 Andersson-Dubin, at Epstein’s request, sought a volunteer position at the center for a young Russian woman. When Mount Sinai’s director of international personnel said the “volunteer tasks” the “foreign national” wanted to perform “potentially conflict with the duties designated for the union,” Andersson-Dubin wrote to Epstein that the young woman could “sit there and just look pretty … if that makes it better!! This woman … has something against Russian girls I think … ,” to which Epstein replied: “socialism.” After Andersson-Dubin appealed to the hospital, the volunteer position was approved.

Family placement. Celina Dubin, the couple’s daughter, was a student at the Icahn School of Medicine and is now an assistant professor of dermatology at Mount Sinai. The daughters of two other billionaires linked to Epstein — Bill Gates’s daughter, who graduated in 2024 and is now a pediatric resident, and US commerce secretary Howard Lutnick’s daughter, who is currently enrolled — have also attended the medical school. Both billionaires have testified in Congress about their relationships with Epstein.

Background relationship. A 2019 New York Times report said Dubin first met Epstein through his wife and provided Epstein with financial advice over a decades-long relationship. The report said Epstein invested $10m in Dubin’s hedge fund and that the two continued to socialize in Palm Beach even after they “parted professional ways.” Andersson-Dubin had dated Epstein before her marriage.

Where the benefits stopped short. After Epstein’s death in jail by suicide in 2019, Mount Sinai said it was “contributing a sum equal to the donations we received from Mr Epstein and his foundation to a charity focused on preventing human trafficking and exploitation.” The hospital declined to answer questions about how much money it donated or to whom.

What happens next

The observable effects are board vacancies, a regulatory review, litigation in motion, and organized protest at a fundraiser. Mount Sinai’s statement about the Dubins is the only causal account it has offered; without the review’s status and findings, a personnel change cannot be read as accountability, because a personnel change signals accountability only when tied to a documented review. The independent legal and regulatory processes continue regardless of the hospital’s silence.

In the short term, attention shifts from individual relationships to records and controls: how donations were accepted, whether trustees disclosed conflicts, how special access was granted, and how research gifts were documented. The near-term determinative events are rulings on Mount Sinai’s summary-judgment motion in the April 2019 employment discrimination suit before US district judge Vernon Broderick, the FirstBank litigation, the review committee’s work, and whatever the hospital discloses or withholds. The New York State Department of Health’s statement — that “the allegations in recent media reports are deeply troubling and clearly warrant review” — sustains an independent regulatory track; the department said it cannot discuss active investigations.

In the medium term, if documents show controls were inadequate, a durable remedy has to change systems rather than rely on individual departures: donor acceptance and benefits, board disclosure and recusal, access to privileged hospital services, care outside institutional facilities, and research-funding documentation. Open questions include the disposition of the Dubin Breast Center’s naming — a patient-facing clinical facility, so the naming decision carries consequences a reputational accounting would omit — the status of Karp’s board seat, and whether Representative Thomas Massie’s House-floor call for investigation produces action by the Department of Justice.

In the long term, documented and enforced reform would establish a more durable model for governing privileged donor relationships; continued ambiguity leaves patient trust, staff confidence, and institutional credibility contested, per the concerns expressed by the state regulator and the employee plaintiffs. Cross-institutional effects run in both directions: other medical centers may tighten gift-acceptance and vetting practices, which can deter legitimate philanthropy along with problematic donors, and the courts’ rulings in these cases set standards for institutional liability.

Separate litigation, regulatory attention, and organized pressure from former employees reinforce one another. Volunteers supporting Equity Now, an organization formed by former Mount Sinai employees who sued the hospital, distributed fliers outside this past summer’s Crystal Party at Chelsea Piers naming Epstein-linked board members. Each track keeps records under scrutiny without a final finding.

Mount Sinai can narrow the dispute by establishing what its reported review examined and what it found; its 2019 equal-amount contribution and the reported creation of a review committee this year are mitigating institutional steps. Neither resolves questions about the underlying relationships. One unintended consequence is already visible: a review whose findings are undisclosed may sustain the scrutiny it was formed to address, because each new article and filing is assessed against the hospital’s silence. The first observable signal would be a written statement on the committee’s status, scope, findings, and timetable for reforms; another board departure without that context would be weaker evidence than a disclosed account of the review process.

How this is being framed

Mount Sinai’s public statements place the departures inside ordinary governance turnover while declining to answer the three questions about its review. Its legal filing in the employment discrimination case called the complaint “nothing less than a malicious instrument of character assassination” and “rife with allegations that are immaterial and/or scandalous.” The hospital declined to comment on the FirstBank lawsuit and on the state regulator’s statement, and did not respond to questions about whether Ting faced consequences. Ting did not respond to the Guardian’s questions. The Dubins’ spokesperson did not respond to questions about the departure or about the volunteer-placement episode.

Two characterizations are in direct conflict at the congressional level. On the House floor last month, Republican congressman Thomas Massie of Kentucky alleged that Dubin was one of 14 “Epstein co-conspirators” who ought to face investigation and possible prosecution. “Perhaps hearing these names,” said Massie, “will shame the Department of Justice into delivering justice.” Massie also named Black. Black has said he is the target of a political witch-hunt, has denied knowledge of Epstein’s alleged crimes, and has sued the House committee after Congress voted unanimously last month to hold him in contempt for refusing subpoenas demanding a deposition and all his nondisclosure agreements. Neither the committee process nor the released files has produced a resolution both sides would recognize.

Advocacy groups and litigants advance their own frames. Ann Olivarius, head of the McAllister Olivarius law firm that filed the 2019 suit, said: “The Epstein connection is what gets attention, but that kind of culture never has just one victim or kind of victim. When powerful institutions let their men mistreat women, it’s usually a feature, not a bug.” The Equity Now fliers read: “WOULD YOU LET THESE MEN RUN YOUR PTA?” and “SO WHY WERE THEY RUNNING MOUNT SINAI?” The FirstBank suit alleges that Epstein’s Mount Sinai donations included at least $50,000 drawn from his Enhanced Education account in June 2014 and were “directly used to fund” his illegal activities, and that Mount Sinai was “linked to individuals known to have recruited for him,” without specifying names. FirstBank said in a legal filing that it provided “routine banking services” to Epstein, did not violate anti-trafficking laws or knowingly facilitate his alleged crimes, and filed a suspicious activity report shortly after Epstein’s 2019 arrest.

The evidentiary registers remain distinct. US district judge Jed Rakoff, who has presided over all Epstein-victim class action lawsuits against banking institutions — settlements totaling $438m — ruled that the newest suit could proceed; that is a procedural ruling, not a merits finding, and FirstBank’s denial stands in the unresolved record. A regulator’s determination that allegations warrant review is not a finding. A floor speech is not an indictment. The 2019 discrimination suit’s allegations await a ruling on Mount Sinai’s motion for summary judgment; they are not findings, and unresolved Epstein questions should not be used to prejudge that case. The Dubins’ statements about what they would have done had they been aware are assertions, not adjudicated facts.

Until the hospital answers whether its Epstein-related review has concluded, what the review found, and whether the departure was connected to it, the record describes a gap between what was documented about Epstein and what Mount Sinai, by its public statements, acted on. The size of that gap, and when it closed, is the central open fact.

Governance domains under scrutiny

The record spans five sub-areas of institutional practice. Board governance and conflicts: conflict disclosures, recusal standards, committee authority, the current/former trustee distinction — Karp’s continued seat makes uniform standards necessary without proving a breach or an exoneration. Philanthropy and donor acceptance: gift agreements, donor benefits, recognition policies, rules governing special access — the Black endowments, the Dubin Breast Center, and the reported “VIP” designation are documented instances of philanthropy converting into institutional standing. Clinical governance and patient safety: privileging standards, treatment settings, outside care, patient consent, handling of donors who also seek services — the reported 2012 townhouse procedure, the volunteer-placement episode with the reportedly “conduit” role, and the state regulator’s statement show why access cannot be analyzed solely as a fundraising matter. Research sponsorship and disclosure: provenance of gifts, acknowledgment language, investigator conflicts — the $50,000 payment and the “Jeffrey Epstein to JT” acknowledgment make this a distinct area. Accountability and disclosure: the review committee’s mandate, public communications, regulatory activity, litigation, employee-complaint systems.

The central node is privileged-access governance: whether donor status can produce special access, board influence, favorable research acknowledgments, or informal channels around ordinary rules. The bridge concepts are donor-status policy (philanthropy and treatment), conflict disclosure (personal relationships and board decisions), and gift documentation (research funding and legal scrutiny). The dependency order runs from donor acceptance and benefits, to conflict identification and resolution, to authorization of access, to clinical and research decisions, to review and disclosure, to external legal or regulatory response. Removing the central node leaves the underlying events as a collection of associations rather than an explanation of how benefits and access were authorized.

The connected fields of practice are nonprofit board governance and fiduciary duty; hospital regulation and quality-of-care oversight; medical ethics, including a procedure performed outside a licensed facility; research-funding transparency; anti-trafficking law and banking liability; employment discrimination; and congressional oversight.

Where scrutiny leads

Priority records are the review committee’s charter, status, and findings; board conflict disclosures and recusal rules; policies governing donor recognition and privileged access; standards for outside care and research sponsorship; the FirstBank pleadings; the regulatory position; and the 2019 discrimination suit tracked separately on its own docket.

The narrow conclusion: the Dubins’ departures change the hospital’s board composition, while the unresolved review leaves institutional controls unverified. The evidence supports scrutiny of systems and decision points, not an assignment of individual responsibility for Epstein’s alleged conduct.

Analytical techniques used in this piece

This analysis applies the methods below. Each links to a short, plain-English explainer you can read and reuse.

Consequences & Sequels
Plays a decision forward to its first- and second-order consequences.
Domain Induction
Builds a working mental model of a domain from the ground up.
Quick Orientation
A fast lay-of-the-land read of an unfamiliar domain.